Company Description
Zhongchao Inc. provides healthcare information, education, and training services in the People’s Republic of China.
The company offers patient management services in the tumor and rare diseases field, internet healthcare services, and pharmaceutical services, and operates an online information platform.
It also provides online and onsite health information services, healthcare education programs, and healthcare training products, including clinical practice training, open classes on popular medical topics, interactive case studies, academic conferences and workshops, continuing education courses, and articles and short videos with educational healthcare content, as well as sells patent drugs.
The company offers its services through its MDMOOC online platform, including the MDMOOC mobile app, MOOC Medical WeChat subscription account, and MDMOOC website, and patient management services through an IT system under the Zhongxun brand, WeChat mini program, and Zhongxin Health WeChat mini program.
It serves enterprises and non-profit organizations, including medical associations, medical institutions, medical journals, medical foundations, and hospitals, as well as healthcare professionals, nurses, doctors, and other healthcare workers.
The company was founded in 2012 and is headquartered in Shanghai, China.
| Country | China |
| Founded | 2012 |
| IPO Date | Feb 24, 2020 |
| Industry | Health Information Services |
| Sector | Healthcare |
| Employees | 111 |
| CEO | Weiguang Yang |
Contact Details
Address: Nanxi Creative Center, Suite 216 Shanghai, 200040 China | |
| Phone | 86 21 3220 5987 |
| Website | izcmd.com |
Stock Details
| Ticker Symbol | ZCMD |
| Exchange | NASDAQ |
| Share Class | Class A Shares |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $4.00 |
| CIK Code | 0001785566 |
| CUSIP Number | G9897X107 |
| ISIN Number | KYG9897X1079 |
| SIC Code | 8200 |
Key Executives
| Name | Position |
|---|---|
| Weiguang Yang | Founder, Chairman, President and Chief Executive Officer |
| Pei Xu | Chief Financial Officer, Secretary and Director |
| Shuang Wu | Chief Operating Officer |
| Baoqian Tian | Chief Sales Officer |
| Xuejun Chen | Chief Medical Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 21, 2025 | EFFECT | Notice of Effectiveness |
| May 6, 2025 | F-3/A | Filing |
| Apr 25, 2025 | 20-F | Annual and transition report of foreign private issuers |
| Feb 27, 2025 | F-3/A | Filing |
| Dec 20, 2024 | 6-K | Report of foreign issuer |
| Dec 19, 2024 | F-3 | Filing |
| Dec 13, 2024 | 6-K | Report of foreign issuer |
| Nov 20, 2024 | 6-K | Report of foreign issuer |
| Nov 6, 2024 | 6-K | Report of foreign issuer |
| Nov 1, 2024 | 6-K | Report of foreign issuer |